Skip to main content

Peer Review reports

From: Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East

Original Submission
7 Dec 2016 Submitted Original manuscript
6 Feb 2017 Reviewed Reviewer Report - Pasquale Annunziata
15 Feb 2017 Reviewed Reviewer Report - Veronica Popescu
4 Apr 2017 Author responded Author comments - Anat Achiron
Resubmission - Version 2
4 Apr 2017 Submitted Manuscript version 2
19 Apr 2017 Reviewed Reviewer Report - Pasquale Annunziata
29 May 2017 Author responded Author comments - Anat Achiron
Resubmission - Version 3
29 May 2017 Submitted Manuscript version 3
30 Jun 2017 Author responded Author comments - Anat Achiron
Resubmission - Version 4
30 Jun 2017 Submitted Manuscript version 4
Publishing
9 Jul 2017 Editorially accepted
7 Aug 2017 Article published 10.1186/s12883-017-0913-3

You can find further information about peer review here.

Back to article page